Branch Banking & Trust Company »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Branch Banking & Trust Company

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Branch Banking & Trust Company from 13F filings

Historical chart of Branch Banking & Trust Company investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Branch Banking & Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Branch Banking & Trust Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $63k 71k 0.88
2025-06-30 $54k 71k 0.76
2025-03-31 $66k 71k 0.93

More positions owned by Branch Banking & Trust Company

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Coca-Cola Company (KO)
Ishares Tr Rus 1000 Grw Etf (IWF)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Branch Banking & Trust Company

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Balyasny Asset Management
Linden Advisors
Highbridge Capital Management
Oaktree Capital Management
D. E. Shaw & Co
DG Capital Management
Calamos Advisors
Davidson Kempner Capital Management
Agf Management
Readystate Asset Management
LMR Partners
State Street Corporation
Silver Point Capital
Man Group
Capstone Investment Advisors

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1